treatment resistance as a key challenge in patients with advanced nsclc
Published 1 year ago • 140 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
1:26
the challenge of treatment resistance in patients with advanced egfr-mutated nsclc
-
1:52
challenges in selecting 2l treatments for patients with advanced nsclc after chemoimmunotherapy
-
1:24
acquired resistance: facing the challenge of immunotherapy in patients with lung cancer
-
1:46
challenges and opportunities for patients with advanced nsclc
-
1:41
key challenges in lung cancer treatment
-
0:42
key challanges in nsclc
-
3:48
overcoming resistance to immune checkpoint inhibitors in nsclc
-
1:27:40
skin, healing and immune response
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
6:55
the prognostic value of ctdna in nsclc treated with neoadjuvant chemoimmunotherapy
-
3:53
how to maximize clinical benefits for patients with alk-positive non-small cell lung cancer
-
1:41
guk1 as a driver of resistance to targeted therapies in lung cancer
-
1:48
adjuvant and neoadjuvant chemo-io for uk patients with nsclc
-
0:55
challenges associated with biomarker testing for pd-l1 in nsclc
-
0:58
challenges and treatment of cns metastases in nsclc
-
8:04
mrx0518 pembro in patients with resistance to therapy
-
2:49
the challenges of treating metex14 nsclc
-
0:47
the role of immunotherapy with kras inhibitors in kras-driven nsclc
-
1:48
results of keynote-024 trial of pembrolizumab in nsclc